Search research articles
Contact Us
Filters
Showing results (301-310 of 350) with videos related to
Page
of 35
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
B Thürlimann, K Beretta, M Bacchi, et al.
British Journal of Haematology
|
June 1, 1997
Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process
F Bertoni, G Cazzaniga, G Bosshard, et al.
British Journal of Cancer
|
February 4, 2010
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial
M Joerger, A D R Huitema, S Krähenbühl, et al.
Cancer Chemotherapy and Pharmacology
|
September 29, 1999
Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243)
C Sessa, M Zucchetti, M Ghielmini, et al.
Israel Journal of Medical Sciences
|
February 1, 1995
The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group
A Goldhirsch, R D Gelber, M Castiglione, et al.
Leukemia & Lymphoma
|
January 24, 2004
Efficacy of vinblastine, bleomycin, methotrexate (VBM) combination chemotherapy with involved field radiotherapy in early stage (I-IIA) Hodgkin disease patients
G Martinelli, E Cocorocchio, P C Saletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2005
In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas
K Lacrima, A Valentini, C Lambertini, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1983
Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group
R De Jager, P Siegenthaler, F Cavalli, et al.
Leukemia & Lymphoma
|
June 14, 2003
ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma
G Martinelli, P F Ferrucci, W Mingrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 18, 2006
Henoch-Schönlein purpura (HSP) during treatment with anastrozole
M Conti-Beltraminelli, O Pagani, G Ballerini, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 350) with videos related to
Sort By:
Page
of 35
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
B Thürlimann, K Beretta, M Bacchi, et al.
British Journal of Haematology
|
June 1, 1997
Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process
F Bertoni, G Cazzaniga, G Bosshard, et al.
British Journal of Cancer
|
February 4, 2010
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial
M Joerger, A D R Huitema, S Krähenbühl, et al.
Cancer Chemotherapy and Pharmacology
|
September 29, 1999
Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243)
C Sessa, M Zucchetti, M Ghielmini, et al.
Israel Journal of Medical Sciences
|
February 1, 1995
The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group
A Goldhirsch, R D Gelber, M Castiglione, et al.
Leukemia & Lymphoma
|
January 24, 2004
Efficacy of vinblastine, bleomycin, methotrexate (VBM) combination chemotherapy with involved field radiotherapy in early stage (I-IIA) Hodgkin disease patients
G Martinelli, E Cocorocchio, P C Saletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2005
In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas
K Lacrima, A Valentini, C Lambertini, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1983
Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group
R De Jager, P Siegenthaler, F Cavalli, et al.
Leukemia & Lymphoma
|
June 14, 2003
ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma
G Martinelli, P F Ferrucci, W Mingrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 18, 2006
Henoch-Schönlein purpura (HSP) during treatment with anastrozole
M Conti-Beltraminelli, O Pagani, G Ballerini, et al.
Page
of 35